Pre-Clinical Testing for Alzheimer's Disease

Developed by the American Academy of Neurology's Geriatric Neurology Section
Moderator: Alexander P. Auchus, MD, AGSF, FAAN, University of Mississippi Medical Center
This session will discuss of the new National Institute on Aging - Alzheimer's Association diagnostic criteria and guidelines for: asymptomatic preclinical stage of AD; MCI due to AD; and dementia due to AD; current and emerging neuroimaging biomarkers for AD including a discussion of resting state networks; and current and emerging blood and CSF biomarkers for AD including screening criteria. 

Overview of the New NIA/Alzheimer's Association Diagnostic Criteria and Guidelines
Alexander P. Auchus, MD, AGSF, FAAN, University of Mississippi Medical Center

Current and Emerging Neuroimaging Biomarkers
Tiffany W. Chow, MD, MS, Baycrest Brain Health

Current and Emerging Blood and CSF Biomarkers
Anil K. Nair MD, Quincy Medical Center